Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Grimes

Showing results (221-230 of 225) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 225 results.
Science (New York, N.Y.)|September 25, 1999
Emerging marine diseases--climate links and anthropogenic factorsC D Harvell, K Kim, J M Burkholder, et al.
British Journal of Cancer|February 28, 2020
5-Azacytidine inhaled dry powder formulation profoundly improves pharmacokinetics and efficacy for lung cancer therapy through genome reprogrammingPhilip J Kuehl, Carmen S Tellez, Marcie J Grimes, et al.
Cancer Research|April 17, 2002
Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokersSteven A Belinsky, William A Palmisano, Frank D Gilliland, et al.
Science (New York, N.Y.)|October 6, 2018
Chemical interactions between Saturn's atmosphere and its ringsJ H Waite, R S Perryman, M E Perry, et al.
Blood|February 14, 2014
A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixaforDavid H McDermott, Qian Liu, Daniel Velez, et al.
Pageof 23

Showing results (221-230 of 225) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 225 results.
Science (New York, N.Y.)|September 25, 1999
Emerging marine diseases--climate links and anthropogenic factorsC D Harvell, K Kim, J M Burkholder, et al.
British Journal of Cancer|February 28, 2020
5-Azacytidine inhaled dry powder formulation profoundly improves pharmacokinetics and efficacy for lung cancer therapy through genome reprogrammingPhilip J Kuehl, Carmen S Tellez, Marcie J Grimes, et al.
Cancer Research|April 17, 2002
Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokersSteven A Belinsky, William A Palmisano, Frank D Gilliland, et al.
Science (New York, N.Y.)|October 6, 2018
Chemical interactions between Saturn's atmosphere and its ringsJ H Waite, R S Perryman, M E Perry, et al.
Blood|February 14, 2014
A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixaforDavid H McDermott, Qian Liu, Daniel Velez, et al.
Pageof 23